Gene · 407036
MIR32: microRNA 32
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MIR32: microRNA 32. Genes, record 407036. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/407036
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants725
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR32 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 3 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 2 | 2025 |
| P30CA023168 | Cancer Center Support Grant | 2 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 2 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 2 | 2025 |
| P30ES001247 | Environmental Agents as Modulators of Disease Processes | 2 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 2 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 2 | 2025 |
1 to 10 of 725Source NIH's project files
See all 725 nih grantsPapers1,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of miRNA-32 in non-small cell lung cancer. | Medicine (Baltimore) | 2026 | 42432883 | PubTator, text mining | PubMed |
| Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer. | Comput Biol Chem | 2026 | 42379114 | PubTator, text mining | PubMed |
| Upregulation of miR-32 in tissue and plasma and its association with PTEN expression in colorectal cancer. | BMC Cancer | 2026 | 42260415 | PubTator, text mining | PubMed |
| SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC. | Cells | 2026 | 41892339 | PubTator, text mining | PubMed |
| Neuroinflammation and NeuroHIV: understanding the role of HIV-1 related factors in microglial activation. | Transl Psychiatry | 2026 | 41856995 | PubTator, text mining | PubMed |
| Special Issue "Molecular and Cellular Research in Pregnancy-Related Complications". | Int J Mol Sci | 2026 | 41751871 | PubTator, text mining | PubMed |
| Chemoresistance: The hidden barrier in cancer treatment. | Cancer Pathog Ther | 2026 | 41550358 | PubTator, text mining | PubMed |
| Deficiency of extracellular vesicles miR-32 from bone marrow mesenchymal stem cells alleviates vascular calcification in type 2 diabetes by inhibiting endothelial ferroptosis. | Stem Cell Res Ther | 2026 | 41519936 | PubTator, text mining | PubMed |
| MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD. | Clin Mol Hepatol | 2026 | 41456859 | PubTator, text mining | PubMed |
| hsa-miR-21-5p can serve as a standard biomarker in clear cell renal cell carcinoma by promoting tumor progression and influencing immune evasion. | Discov Oncol | 2025 | 41003869 | PubTator, text mining | PubMed |
1 to 10 of 1,400
See all 1,400 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/407036
GET https://conductscience.org/api/genes/v1/407036/grants?page=2